-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Neutral on RXO, Raises Price Target to $22

Benzinga·05/08/2026 21:40:39
Listen to the news
UBS analyst Thomas Wadewitz maintains RXO (NYSE:RXO) with a Neutral and raises the price target from $17 to $22.